黑人男性前列腺活检风险计算器的开发与验证
研究前瞻性招募芝加哥5家机构的两个黑人男性队列(393例和292例),开发并验证预测Gleason分级分组(GG)≥2前列腺癌的活检风险计算器,与现有三种计算器比较。Mistry-Sun模型C统计量为0.74、0.74、0.78,在10%和30%风险阈值下不必要活检最少且漏诊GG≥2前列腺癌比例适当。
要点
- 开发了3个Mistry-Sun模型预测黑人男性GG≥2前列腺癌,C统计量0.74-0.78。
- 在10%和30%风险阈值下,模型不必要活检最少且漏诊比例适当。
- 针对黑人男性定制的风险计算器可能改善活检决策和结局。
核心结论
- 针对黑人男性定制的风险计算器在检测临床显著前列腺癌方面可能改善活检决策和结局。
研究设计与样本
- 前瞻性招募两个黑人男性队列,分别来自芝加哥5家机构,第一个队列分为开发组(70%)和内部验证组(30%),第二个队列用于外部验证。
- 两个队列分别纳入393例和292例接受前列腺活检的黑人男性。
- 使用迭代逻辑回归开发3个预测GG≥2前列腺癌的模型,采用C统计量、校准曲线和净获益曲线比较判别能力。
主要发现
- Mistry-Sun 1模型使用血清PSA和既往阴性活检。
- Mistry-Sun 2在Mistry-Sun 1基础上加入异常直肠指检(DRE)及异常DRE与PSA的交互项。
- Mistry-Sun 3在Mistry-Sun 1基础上加入前列腺体积、异常DRE和年龄。
- 三个模型的C统计量分别为0.74、0.74和0.78,与现有计算器相似或更高。
- 在10%和30%风险阈值下,模型的不必要活检最少,漏诊GG≥2前列腺癌比例适当。
关键数值与推荐
- 在10%和30%风险阈值下比较不必要活检频率和漏诊前列腺癌。
- Mistry-Sun 1的C统计量为0.74,Mistry-Sun 2为0.74,Mistry-Sun 3为0.78。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We sought to develop and validate a prostate biopsy risk calculator for Black men and compare it with the Prostate Cancer Prevention Trial version 2.0, Prostate Biopsy Collaborative Group, and Kaiser Permanente Prostate Cancer Risk Calculators for the detection of Gleason Grade Group (GG) ≥ 2 prostate cancer (PCa). MATERIALS AND METHODS: We prospectively recruited 2 cohorts of men undergoing prostate biopsy from 5 facilities in Chicago. The first cohort was split into development (70%) and internal validation (30%) groups. The second was used for external validation. Iterative logistic regression was used to develop 3 models for predicting GG ≥ 2 PCa. Models were compared for discrimination using the C statistics, calibration curves, and net benefit curves. The frequency of unnecessary biopsies and missed PCas was compared at 10% and 30% risk thresholds. RESULTS: The 2 cohorts included 393 and 292 Black men, respectively. Our first model, Mistry-Sun 1, used serum PSA and prior negative biopsy. Mistry-Sun 2 added abnormal digital rectal exam (DRE) and an interaction term with abnormal DRE and PSA to Mistry-Sun 1. Mistry-Sun 3 added prostate volume, abnormal DRE, and age to Mistry-Sun 1. The C statistics were 0.74, 0.74, and 0.78, respectively, and were similar to or higher than established calculators. At the 10% and 30% risk thresholds our models had the fewest unnecessary biopsies and an appropriate proportion of missed GG ≥ 2 PCas. CONCLUSIONS: Tailoring a risk calculator to detect clinically significant PCa in Black men may improve biopsy decision-making and outcomes compared to tools developed in non-Black populations.
引用
- Mistry NA, Sun Z, Sweis J, et al. Development and Validation of a Prostate Biopsy Risk Calculator in Black Men. J Urol. 2023. PMID: 37917725. doi:10.1097/JU.0000000000003774
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。